High Added Value – but Many Stumbling Blocks along the Way NTN Biotech Identifies where the Shoe Pinches
Biotechnet Switzerland
DOI:
https://doi.org/10.2533/chimia.2016.118Keywords:
Antibiotics, Biotechnology, DnaAbstract
The year 1958, when DNA was first made in a test tube, marked the birth of modern biotechnology. DNA has now developed into an important technology that makes a key contribution in various sectors such as agriculture, environment and cleansing, and it has triggered a veritable boom in medicine. Today, biologics account for more than 60% of newly approved drugs. They are efficient, save time and money and have few or minimal side effects, fuelling the appetite of big pharma to take over biotech companies. Where will the journey lead?Downloads
Published
2016-02-24
Issue
Section
Columns, Conference Reports
Categories
License
Copyright (c) 2016 Swiss Chemical Society
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
[1]
E. Heinzelmann, Chimia 2016, 70, 118, DOI: 10.2533/chimia.2016.118.